$60,000 of CME GROUP INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to futures industry including digital asset policy and H.R.3633 - Digital Asset Market Clarity Act of 2025."
You can find more data on corporate lobbying on Quiver Quantitative.
CME Congressional Stock Trading
Members of Congress have traded $CME stock 5 times in the past 6 months. Of those trades, 3 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CME stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON has traded it 3 times. They made 2 purchases worth up to $30,000 on 08/11, 07/22 and 1 sale worth up to $15,000 on 08/14.
- REPRESENTATIVE VAL T. HOYLE purchased up to $15,000 on 05/21.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CME Insider Trading Activity
CME insiders have traded $CME stock on the open market 22 times in the past 6 months. Of those trades, 4 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $CME stock by insiders over the last 6 months:
- SUNIL CUTINHO (Chief Information Officer) has made 0 purchases and 2 sales selling 11,896 shares for an estimated $3,229,444.
- DEREK SAMMANN (Sr MD Gl Hd Commodities Mkts) has made 0 purchases and 2 sales selling 4,650 shares for an estimated $1,304,847.
- LARRY G GERDES has made 0 purchases and 3 sales selling 4,000 shares for an estimated $1,060,441.
- CHARLES P CAREY has made 0 purchases and 3 sales selling 3,500 shares for an estimated $950,356.
- JONATHAN L MARCUS (Sr MD General Counsel) has made 0 purchases and 3 sales selling 1,158 shares for an estimated $308,297.
- PHYLLIS M LOCKETT sold 1,060 shares for an estimated $294,552
- DENNIS SUSKIND sold 1,000 shares for an estimated $271,280
- WILLIAM R SHEPARD has made 4 purchases buying 541 shares for an estimated $145,007 and 0 sales.
- DANIEL G KAYE sold 500 shares for an estimated $141,209
- TIMOTHY FRANCIS MCCOURT (Sr MD Global Head Equity & FX) sold 379 shares for an estimated $98,475
- MARTIN J GEPSMAN sold 300 shares for an estimated $81,951
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CME Hedge Fund Activity
We have seen 823 institutional investors add shares of CME stock to their portfolio, and 640 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 3,048,375 shares (+305.7%) to their portfolio in Q2 2025, for an estimated $840,193,117
- BLACKROCK, INC. removed 2,571,288 shares (-7.9%) from their portfolio in Q2 2025, for an estimated $708,698,398
- GQG PARTNERS LLC added 1,368,647 shares (+62.1%) to their portfolio in Q2 2025, for an estimated $377,226,486
- MORGAN STANLEY removed 1,124,021 shares (-10.6%) from their portfolio in Q2 2025, for an estimated $309,802,668
- CAPITAL WORLD INVESTORS removed 1,109,855 shares (-11.4%) from their portfolio in Q2 2025, for an estimated $305,898,235
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 983,290 shares (-70.5%) from their portfolio in Q2 2025, for an estimated $271,014,389
- NORGES BANK added 932,997 shares (+19.6%) to their portfolio in Q2 2025, for an estimated $257,152,633
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CME Analyst Ratings
Wall Street analysts have issued reports on $CME in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 10/01/2025
- JP Morgan issued a "Underweight" rating on 09/25/2025
- Citigroup issued a "Buy" rating on 09/25/2025
- Oppenheimer issued a "Outperform" rating on 07/24/2025
- Piper Sandler issued a "Overweight" rating on 07/15/2025
To track analyst ratings and price targets for CME, check out Quiver Quantitative's $CME forecast page.
CME Price Targets
Multiple analysts have issued price targets for $CME recently. We have seen 9 analysts offer price targets for $CME in the last 6 months, with a median target of $298.0.
Here are some recent targets:
- Patrick Moley from Morgan Stanley set a target price of $312.0 on 10/01/2025
- Kenneth Worthington from JP Morgan set a target price of $252.0 on 09/25/2025
- Christopher Allen from Citigroup set a target price of $300.0 on 09/25/2025
- Alex Kramm from UBS set a target price of $285.0 on 09/08/2025
- Owen Lau from Oppenheimer set a target price of $303.0 on 07/24/2025
- Benjamin Budish from Barclays set a target price of $298.0 on 07/24/2025
- Patrick Moley from Piper Sandler set a target price of $296.0 on 07/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
